Kuano
Kuano offers a computational drug design platform that helps researchers identify safer, more efficient drug candidates faster. It combines quantum mapping, AI and machine-learning-driven simulations through its proprietary Quantum Lens technology to model binding, reactivity and subtle electronic features that conventional methods miss. The platform integrates quantum chemistry, in silico simulation, and medicinal chemistry workflows to support design of enzyme inhibitors, allosteric binders, covalent ligands and other modalities. Kuano operates as a B2B platform working with pharmaceutical and biotech organizations on target-driven discovery and inhibitor design.
Kuano
Kuano offers a computational drug design platform that helps researchers identify safer, more efficient drug candidates faster. It combines quantum mapping, AI and machine-learning-driven simulations through its proprietary Quantum Lens technology to model binding, reactivity and subtle electronic features that conventional methods miss. The platform integrates quantum chemistry, in silico simulation, and medicinal chemistry workflows to support design of enzyme inhibitors, allosteric binders, covalent ligands and other modalities. Kuano operates as a B2B platform working with pharmaceutical and biotech organizations on target-driven discovery and inhibitor design.
